Rampersaud, Y. Raja
Sundararajan, Kala
Docter, Shgufta
Perruccio, Anthony V.
Gandhi, Rajiv
Adams, Diana
Briggs, Natasha
Davey, J. Rod
Fehlings, Michael
Lewis, Stephen J.
Magtoto, Rosalie
Massicotte, Eric
Sarro, Angela
Syed, Khalid
Mahomed, Nizar N.
Veillette, Christian
Funding for this research was provided by:
Arthritis Society (STAR-20-0000000012)
Article History
Received: 3 November 2022
Accepted: 23 September 2023
First Online: 25 October 2023
Declarations
:
: This study was approved by the University Health Network Research Ethics Board (#10–0677), and all methods were carried out in accordance with the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2) and the Declaration of Helsinki. The need for informed consent was waived by the University Health Network Research Ethics Board because of the retrospective nature of the study.
: Not applicable.
: Dr. Y. R. Rampersaud has received royalties from Medtronic and holds investments in Arthur Health Corporation. Dr. N. Mahomed holds investments in Arthur Health Corporation and Arthritis Innovation Corporation. All other authors have no conflicts to disclose.